Evolent Health, Inc. (EVH)
USD 10.69
(7.44%)
USD 10.69
(7.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -113.04 Million USD | -504.46% |
| 2022 | -18.7 Million USD | 38.25% |
| 2021 | -30.28 Million USD | 90.94% |
| 2020 | -334.24 Million USD | -9.38% |
| 2019 | -305.58 Million USD | -480.31% |
| 2018 | -52.65 Million USD | 13.2% |
| 2017 | -60.66 Million USD | 62.02% |
| 2016 | -159.74 Million USD | -148.04% |
| 2015 | 332.49 Million USD | 1417.02% |
| 2014 | -25.24 Million USD | -226.09% |
| 2013 | 20.02 Million USD | 203.95% |
| 2012 | -19.26 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.59 Million USD | 109.24% |
| 2024 Q1 | -17.28 Million USD | 48.28% |
| 2023 Q2 | -34.32 Million USD | -71.77% |
| 2023 Q4 | -33.41 Million USD | -31.93% |
| 2023 FY | -113.04 Million USD | -504.46% |
| 2023 Q3 | -25.32 Million USD | 26.22% |
| 2023 Q1 | -19.98 Million USD | -76.07% |
| 2022 FY | -18.7 Million USD | 38.25% |
| 2022 Q2 | -4.12 Million USD | 22.9% |
| 2022 Q3 | 2.12 Million USD | 151.47% |
| 2022 Q1 | -5.35 Million USD | 5.26% |
| 2022 Q4 | -11.34 Million USD | -634.57% |
| 2021 Q3 | -13.04 Million USD | -43.19% |
| 2021 Q4 | -5.64 Million USD | 56.69% |
| 2021 Q1 | -9.8 Million USD | 32.94% |
| 2021 Q2 | -9.1 Million USD | 7.14% |
| 2021 FY | -30.28 Million USD | 90.94% |
| 2020 Q3 | -37.34 Million USD | 81.65% |
| 2020 Q2 | -203.52 Million USD | -161.76% |
| 2020 FY | -334.24 Million USD | -9.38% |
| 2020 Q4 | -14.62 Million USD | 60.84% |
| 2020 Q1 | -77.75 Million USD | 60.75% |
| 2019 FY | -305.58 Million USD | -480.31% |
| 2019 Q1 | -46.73 Million USD | -180.09% |
| 2019 Q4 | -198.09 Million USD | -676.21% |
| 2019 Q3 | -25.52 Million USD | 19.28% |
| 2019 Q2 | -31.61 Million USD | 32.36% |
| 2018 FY | -52.65 Million USD | 13.2% |
| 2018 Q4 | -16.68 Million USD | -34.26% |
| 2018 Q2 | -9.91 Million USD | 27.23% |
| 2018 Q1 | -13.62 Million USD | -3.54% |
| 2018 Q3 | -12.42 Million USD | -25.34% |
| 2017 FY | -60.66 Million USD | 62.02% |
| 2017 Q4 | -13.16 Million USD | -4.54% |
| 2017 Q3 | -12.58 Million USD | 25.54% |
| 2017 Q2 | -16.9 Million USD | 6.15% |
| 2017 Q1 | -18.01 Million USD | -3.48% |
| 2016 Q1 | -122.81 Million USD | -2881.6% |
| 2016 FY | -159.74 Million USD | -148.04% |
| 2016 Q4 | -17.4 Million USD | -55.31% |
| 2016 Q3 | -11.2 Million USD | -33.64% |
| 2016 Q2 | -8.38 Million USD | 93.17% |
| 2015 FY | 332.49 Million USD | 1417.02% |
| 2015 Q2 | 359.01 Million USD | 1958.75% |
| 2015 Q3 | -11.98 Million USD | -103.34% |
| 2015 Q4 | -4.11 Million USD | 65.62% |
| 2015 Q1 | -19.31 Million USD | -80.55% |
| 2014 Q3 | -3.16 Million USD | 46.67% |
| 2014 Q2 | -5.93 Million USD | 48.92% |
| 2014 Q4 | -10.69 Million USD | -237.8% |
| 2014 Q1 | -11.62 Million USD | -146.31% |
| 2014 FY | -25.24 Million USD | -226.09% |
| 2013 FY | 20.02 Million USD | 203.95% |
| 2013 Q4 | 25.1 Million USD | 0.0% |
| 2012 FY | -19.26 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Well Corporation | -675.16 Million USD | 83.257% |
| Doximity, Inc. | 147.58 Million USD | 176.595% |
| MultiPlan Corporation | -91.69 Million USD | -23.276% |
| Phreesia, Inc. | -136.88 Million USD | 17.42% |
| Teladoc Health, Inc. | -220.36 Million USD | 48.704% |
| Veeva Systems Inc. | 525.7 Million USD | 121.503% |